Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05498272
Title Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations (NePtune)
Acronym NePtune
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Rana McKay, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego - Moores Cancer Center RECRUITING La Jolla California 92093 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center RECRUITING Baltimore Maryland 21287 United States Details
Columbia University Irving Medical Center RECRUITING New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Penn Medicine Abramson Cancer Center RECRUITING Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field